Andlauer Healthcare Group Inc. (AND.TO)

CAD 41.0

(0.79%)

EBITDA Summary of Andlauer Healthcare Group Inc.

Andlauer Healthcare Group Inc.'s latest annual EBITDA in 2023 was 164.2 Million CAD , down -6.21% from previous year.
Andlauer Healthcare Group Inc.'s latest quarterly EBITDA in 2024 Q2 was 39.77 Million CAD , up 0.49% from previous quarter.
Andlauer Healthcare Group Inc. reported an annual EBITDA of 175.06 Million CAD in 2022, up 46.56% from previous year.
Andlauer Healthcare Group Inc. reported an annual EBITDA of 154.9 Million CAD in 2021, up 50.83% from previous year.
Andlauer Healthcare Group Inc. reported a quarterly EBITDA of 39.58 Million CAD for 2024 Q1, down -12.75% from previous quarter.
Andlauer Healthcare Group Inc. reported a quarterly EBITDA of N/A for 2023 FY, down -6.21% from previous quarter.

Annual EBITDA Chart of Andlauer Healthcare Group Inc. (2023 - 2016)

Historical Annual EBITDA of Andlauer Healthcare Group Inc. (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	164.2 Million CAD	-6.21%
2022	175.06 Million CAD	46.56%
2021	154.9 Million CAD	50.83%
2020	79.19 Million CAD	10.68%
2019	71.55 Million CAD	9.66%
2018	65.25 Million CAD	11.61%
2017	58.46 Million CAD	10.5%
2016	52.91 Million CAD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	39.77 Million CAD	0.49%
2024 Q1	39.58 Million CAD	-12.75%
2023 FY	- CAD	-6.21%
2023 Q4	45.36 Million CAD	13.26%
2023 Q3	40.05 Million CAD	-0.6%
2023 Q2	40.29 Million CAD	-1.88%
2023 Q1	41.06 Million CAD	-8.9%
2022 Q1	39.49 Million CAD	-46.42%
2022 FY	- CAD	46.56%
2022 Q4	45.08 Million CAD	2.09%
2022 Q3	44.15 Million CAD	-4.69%
2022 Q2	46.33 Million CAD	17.3%
2021 FY	- CAD	50.83%
2021 Q4	73.72 Million CAD	162.82%
2021 Q3	28.05 Million CAD	-6.52%
2021 Q2	30 Million CAD	17.26%
2021 Q1	25.59 Million CAD	16.31%
2020 Q4	22 Million CAD	8.66%
2020 Q3	20.25 Million CAD	12.54%
2020 Q2	17.99 Million CAD	-5.06%
2020 Q1	18.95 Million CAD	4.45%
2020 FY	- CAD	10.68%
2019 FY	- CAD	9.66%
2019 Q3	18 Million CAD	-0.19%
2019 Q2	18.03 Million CAD	3.27%
2019 Q1	17.46 Million CAD	15.45%
2019 Q4	18.14 Million CAD	0.78%
2018 FY	- CAD	11.61%
2018 Q3	10.27 Million CAD	0.0%
2018 Q4	15.12 Million CAD	47.22%
2017 FY	- CAD	10.5%
2016 FY	- CAD	0.0%

Peer EBITDA Comparison of Andlauer Healthcare Group Inc.

Name	EBITDA	EBITDA Difference
Cargojet Inc.	287 Million CAD	42.787%
Titanium Transportation Group Inc.	56.51 Million CAD	-190.541%